The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.

A psychoeducational intervention for extrapulmonary manifestations of severe asthma was found feasible and rated as ...

The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...

With the earlier definition of chronic obstructive pulmonary disease (COPD), patients were essentially defined as having either chronic bronchitis or emphysema, with emphysema classified as a ...

With early recognition of patients at particular risk for severe pulmonary hypertension, management strategies can be directed at preventing or minimizing hemodynamic instability and thereby ...

Also, Mike Hess, MPH, RRT, RPFT, senior director of patient outreach and education at the COPD Foundation, shares his Perspective. Read more. Tezepelumab decreases exacerbation rate, improves lung ...

Patient education matters for diseases like multiple myeloma and other cancers. Experts say when patients learn more about their disease and understand options, it can have a big impact on treatment ...